EP Patent

EP3430400A4 — DOSAGE SCHEMES FOR THE TREATMENT OF FUNGAL INFECTIONS

Assigned to Cidara Therapeutics Inc · Expires 2019-10-30 · 7y expired

What this patent protects

Patent listed against rezafungin-acetate.

Drugs covered by this patent

rezafungin-acetate (REZAFUNGIN ACETATE)

Patent Metadata

Patent number: EP3430400A4
Jurisdiction: EP
Classification: —
Expires: 2019-10-30
Drug substance claim: No
Drug product claim: No
Assignee: Cidara Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.